Literature DB >> 12503862

Low vertebral cancellous bone density in peripubertal girls with Turner's syndrome and boys with hypogonadism.

K Nanao1, Y Tsuchiya, S Kotoh, Y Hasegawa.   

Abstract

OBJECTIVE: To characterize the changes of vertebral cancellous bone density in children with hypogonadism. STUDY
DESIGN: Quantitative computed tomography (QCT) values of vertebral cancellous bone in 21 girls with Turner's syndrome, 12 boys with hypogonadism, and 46 age-matched controls (24 boys, 22 girls) were studied. The subjects were divided into the following subgroups by the age (year) at the time of the measurement: A. 4-6.9; B. 7-9.9; C. 10-12.9.
RESULTS: QCT values for Turner's syndrome vs control girls in the same age groups (A, B, and C) were (mean +/- SD) 226 +/- 36 vs 216 +/- 31 (NS), 193 +/- 29 vs 220 +/- 33 (NS), and 177 +/- 32 vs 217 +/- 17 (p < 0.01) mg/cm3, respectively. Those for boys with hypogonadism vs control boys (A, B, and C) were 236 +/- 15 vs 240 +/- 12 (NS), 187 +/- 21 vs 225 +/- 28 (p < 0.05), and 172 +/- 11 vs 216 +/- 26 (p < 0.0001) mg/cm, respectively. The cross-sectional data for Turner's syndrome and boys with hypogonadism had significant negative correlation with chronological age (r = 0.59; p < 0.001).
CONCLUSION: These results showed that vertebral cancellous bone density in children with hypogonadism began to decrease during the peripubertal period in contrast to the constant values in controls, suggesting that a small amount of gonadal steroid in healthy children has an important role in maintaining normal bone density.

Entities:  

Mesh:

Year:  2002        PMID: 12503862     DOI: 10.1515/jpem.2002.15.9.1537

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Bone size and density measurements in prepubertal children with Turner syndrome prior to growth hormone therapy.

Authors:  P Pitukcheewanont; N Numbenjapon; D Safani; S Rossmiller; V Gilsanz; G Costin
Journal:  Osteoporos Int       Date:  2010-09-09       Impact factor: 4.507

Review 2.  Ultra-low-dose estrogen therapy for female hypogonadism.

Authors:  Yukihiro Hasegawa; Tomoyo Itonaga; Kento Ikegawa; Satsuki Nishigaki; Masanobu Kawai; Eri Koga; Hideya Sakakibara; Judith L Ross
Journal:  Clin Pediatr Endocrinol       Date:  2020-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.